Epidemiological analysis of HPV in Sichuan during 2014-2021.
暂无分享,去创建一个
F. Xue | Jiaoyu He | Lushuang Xu | Ning Li | C. Cheng | Rongwu Liang | Qiaoying Zhu | Yanyan Shi | H. Luo | Shaolan Yu
[1] Juan Zhao,et al. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China , 2017, Journal of medical virology.
[2] Xianping Ding,et al. L1 and L2 gene polymorphisms in HPV-58 and HPV-33: implications for vaccine design and diagnosis , 2016, Virology Journal.
[3] Mengting Wang,et al. Genetic variability in E6, E7, and L1 genes of human papillomavirus genotype 52 from Southwest China. , 2016, Gene.
[4] Xianping Ding,et al. Characteristics of HPV prevalence in Sichuan Province, China , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[5] C. Mahidol,et al. Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs , 2015, Infectious Agents and Cancer.
[6] H. Warke,et al. Variations in immunogenetics, human papillomavirus (HPV) infection & predisposition to cervical cancer in Indian women , 2014, The Indian journal of medical research.
[7] J. Salmerón,et al. The Peru Cervical Cancer Screening Study (PERCAPS): The Design and Implementation of a Mother/Daughter Screen, Treat, and Vaccinate Program in the Peruvian Jungle , 2014, Journal of Community Health.
[8] J. Archambault,et al. The E1 proteins. , 2013, Virology.
[9] R. DeSalle,et al. Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67 , 2011, PloS one.
[10] F. Zhang,et al. Human Papillomavirus Type 16 Variant Analysis of E6, E7, and L1 Genes and Long Control Region in Identification of Cervical Carcinomas in Patients in Northeast China , 2011, Journal of Clinical Microbiology.
[11] Shulan Zhang,et al. Characteristics of HPV prevalence among women in Liaoning province, China , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[12] M. Wu,et al. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study , 2009, British Journal of Cancer.
[13] Abdelatif Elouahabi,et al. Cervarix™, the GSK HPV-16/HPV-18 AS04-adjuvanted cervical cancer vaccine, demonstrates stability upon long-term storage and under simulated cold chain break conditions , 2009, Human vaccines.
[14] D. Weiner,et al. Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques. , 2008, Vaccine.
[15] C. Nishida,et al. Development of a WHO growth reference for school-aged children and adolescents. , 2007, Bulletin of the World Health Organization.
[16] A. Giuliano,et al. Prevalence of HPV infection among men: A systematic review of the literature. , 2006, The Journal of infectious diseases.
[17] P. Coursaget,et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. , 2003, The Journal of infectious diseases.
[18] R. Pötter,et al. Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer , 2002, International journal of cancer.